U.S. Markets closed

Vanda Pharmaceuticals Inc. (VNDA)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
15.90-0.15 (-0.93%)
At close: 4:00PM EDT
People also watch
SPPIXNPTACOROSIRPGNX
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue146,017109,92550,157
Cost of Revenue24,71223,4621,583
Gross Profit121,30586,46348,574
Operating Expenses
Research Development29,15629,14519,230
Selling General and Administrative99,78784,53184,644
Non Recurring---
Others10,93312,9722,254
Total Operating Expenses---
Operating Income or Loss-18,571-40,18520,062
Income from Continuing Operations
Total Other Income/Expenses Net66532077,740
Earnings Before Interest and Taxes-17,906-39,86520,186
Interest Expense---
Income Before Tax-17,906-39,86520,186
Income Tax Expense104--
Minority Interest---
Net Income From Continuing Ops-18,010-39,86520,186
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-18,010-39,86520,186
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-18,010-39,86520,186